Dr. Reddy's Laboratories ... (RDY)
NYSE: RDY
· Real-Time Price · USD
14.21
0.10 (0.71%)
At close: Aug 15, 2025, 3:03 PM
Dr. Reddy's Laboratories Cash Flow Statement
Financials in INR. Fiscal
year is
April - March.
| Fiscal Year | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 |
Net Income | 14.1B | 15.87B | 14.04B | 13.41B | 13.92B | 13.07B | 13.79B | 14.8B | 14.03B | 25.01B | 12.47B | 11.13B | 11.88B | 875M | 7.07B | 9.92B | 5.71B | 5.54B | 198M | 7.62B | 5.79B |
Depreciation & Amortization | 4.76B | 4.55B | 4.72B | 3.98B | 3.81B | 3.71B | 3.77B | 3.79B | 3.57B | 3.06B | 3.27B | 3.13B | 3.05B | 2.96B | 2.98B | 2.98B | 2.9B | 3.17B | 3.22B | 3.27B | 3.14B |
Stock-Based Compensation | 112M | 113M | 103M | 107M | 101M | 97M | 99M | 103M | 108M | 21M | 113M | 117M | 146M | 141M | 161M | 143M | 147M | 129M | 151M | 161M | 143M |
Other Working Capital | 2.77B | -804M | -737M | 620M | -6.03B | 4.55B | -6.65B | 7.31B | -3.54B | 6.69B | 6.31B | -12.55B | -5.65B | -485M | 6.63B | -8.02B | -6.71B | 2.97B | -3.78B | -680M | 3.08B |
Other Non-Cash Items | -1.1B | -3.31B | -7.3B | -6.15B | -1.09B | -54M | -5.53B | -7.71B | -2.72B | -14.55B | -2.49B | -289M | -4.62B | 5.09B | -2.17B | -3.76B | -1.85B | -1.97B | 5.01B | -166M | -592M |
Deferred Income Tax | 4.95B | 4.18B | 4.7B | 5.75B | 4.9B | 2.95B | 4.47B | 4.33B | 4.44B | 3.66B | 3.88B | 4.98B | 2.78B | 1.61B | 2.64B | 2.76B | 1.72B | 2.54B | 2.65B | 998M | 3B |
Change in Working Capital | -8.19B | 584M | -9.65B | -7.78B | -13.14B | -2.76B | -11.86B | 2.61B | -8.17B | 2.48B | 6.02B | -9.78B | -6.57B | -1.55B | 6.66B | -6.95B | -12.07B | 1.86B | -6.95B | -2.63B | -567M |
Operating Cash Flow | 14.63B | 22B | 6.62B | 9.32B | 8.5B | 11.52B | 4.74B | 17.93B | 11.25B | 19.68B | 23.26B | 9.28B | 6.66B | 9.12B | 17.33B | 5.11B | -3.45B | 11.27B | 4.27B | 9.25B | 10.91B |
Capital Expenditures | -10.15B | -11.25B | -8.82B | -7.91B | -6.42B | -6.28B | -5.04B | -3.94B | -12.17B | -3.75B | -3.1B | -3.33B | -8.69B | -4.03B | -4.47B | -7.21B | -3.34B | -3.2B | -4.79B | -2.67B | -1.89B |
Cash Acquisitions | -51M | -1.66B | n/a | -51.44B | n/a | n/a | 5.04B | 3.94B | 12.17B | n/a | n/a | n/a | n/a | -326M | n/a | 3.63B | 137M | 15.3B | 1.93B | -524M | -14.99B |
Purchase of Investments | -51.6B | -62.05B | -54.08B | -76.59B | -61.74B | -40.31B | -35.17B | -40.4B | -29.61B | -48.46B | -40.7B | -19.87B | -27.14B | -48.2B | -10.67B | -11.57B | -18.52B | -16.54B | -7.94B | -16.91B | -34.02B |
Sales Maturities Of Investments | 41.74B | 60.28B | 56.31B | 115.72B | 47.27B | 34.77B | 23.2B | 38.65B | 33.16B | 36.19B | 17.22B | 28.75B | 30.64B | 30.19B | 12.09B | 19.54B | 15.96B | 10.12B | 16.11B | 18.62B | 34.67B |
Other Investing Acitivies | -2.42B | -2.22B | -485M | 1.09B | -668M | -6.11B | -4.22B | -2.77B | -11.79B | 248M | 169M | 180M | 262M | 380M | 298M | -416M | 160M | -15.12B | -1.54B | 238M | 509M |
Investing Cash Flow | -19.19B | -13.3B | -5.46B | -19.07B | -20.25B | -11.35B | -16.18B | -4.52B | -8.24B | -15.77B | -26.41B | 5.73B | -4.92B | -21.99B | -2.76B | 3.97B | -5.61B | -9.45B | 3.76B | -1.25B | -15.72B |
Debt Repayment | -256M | -5.15B | 1.52B | 16.55B | 10.27B | n/a | n/a | n/a | -991M | -4.13B | -199M | -7.07B | -10.29B | 5.4B | -176M | -202M | 2.46B | -189M | -7.19B | -2.06B | 1.75B |
Common Stock Repurchased | n/a | -1.39B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1B | n/a | -190M | n/a |
Dividend Paid | n/a | n/a | n/a | -6.66B | n/a | n/a | n/a | -6.65B | n/a | n/a | n/a | -4.98B | n/a | n/a | n/a | -4.15B | n/a | -4.13B | n/a | -4.15B | n/a |
Other Financial Acitivies | -1.14B | 6.21B | -956M | -937M | -744M | -564M | 5.27B | -1.07B | -564M | -389M | 701M | -331M | -541M | -313M | -2.44B | -3B | -342M | 13.94B | -436M | -2.25B | 5.33B |
Financial Cash Flow | -1.2B | -7.37B | 590M | 16.15B | 9.54B | -533M | 5.28B | -7.04B | -1.48B | -4.3B | 583M | -12.35B | -10.8B | 5.1B | -2.57B | -7.21B | 2.26B | 8.64B | -7.55B | -8.56B | 7.18B |
Net Cash Flow | -5.59B | 1.56B | 1.75B | 6.37B | -2.19B | -428M | -6B | 6.31B | 1.45B | -480M | -2.83B | 2.8B | -8.55B | -7.12B | 12B | 1.81B | -6.65B | 10.5B | 533M | -612M | 2.44B |
Free Cash Flow | 4.48B | 10.75B | -2.2B | 1.41B | 2.07B | 5.24B | -305M | 13.99B | -921M | 15.93B | 20.16B | 5.95B | -2.04B | 5.09B | 12.86B | -2.1B | -6.79B | 8.06B | -522M | 6.58B | 9.02B |